Biotech Stocks
Capital Impact Advisors LLC Sells 26,055 Shares of Exelixis, Inc.
MarketBeat
Dec 14, 2025
Capital Impact Advisors LLC reduced its holdings in Exelixis, Inc. by 12.9% during the second quarter, selling 26,055 shares. Despite the sale, Exelixis remains a significant part of their portfolio, accounting for about 2.4% of their investments.
Discussion
Sign in to join the discussion. Comments loading…